Inflammatory breast cancer appearance at presentation is associated with overall survival

被引:7
|
作者
Balema, Wintana [1 ,2 ,3 ]
Liu, Diane [4 ]
Shen, Yu [4 ]
El-Zein, Randa [5 ]
Debeb, Bisrat G. [1 ,6 ]
Kai, Megumi [2 ,3 ]
Overmoyer, Beth [7 ]
Miller, Kathy D. [8 ]
Le-Petross, Huong T. [2 ,3 ]
Ueno, Naoto T. [1 ,6 ]
Woodward, Wendy A. [1 ,2 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA
[2] Morgan Welch IBC Clin, Dept Radiat Oncol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Res Program, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Houston Methodist Canc Ctr, Dept Radiol, Houston, TX USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源
CANCER MEDICINE | 2021年 / 10卷 / 18期
关键词
breast cancer; breast swelling; erythema; IBC; peau d'orange; redness; skin thickening; T4D; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; CLINICAL MANAGEMENT; DIAGNOSIS; LYMPHANGIOGENESIS; CARCINOMA; CONSENSUS; CENTERS; PROGRAM; BIOLOGY; TIME;
D O I
10.1002/cam4.4170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Inflammatory breast cancer (IBC) is a clinical diagnosis. Here, we examined the association of a "classic" triad of clinical signs, swollen involved breast, nipple change, and diffuse skin change, with overall survival (OS). Method Breast medical photographs from patients enrolled on a prospective IBC registry were scored by two independent reviewers as classic (triad above), not classic, and difficult to assign. Chi-squared test, Fisher's exact test, and Wilcoxon rank-sum test were used to assess differences between patient groups. Kaplan-Meier estimates and the log-rank test and Cox proportional hazard regression were used to assess the OS. Results We analyzed 245 IBC patients with median age 54 (range 26-81), M0 versus M1 status (157 and 88 patients, respectively). The classic triad was significantly associated with smoking, post-menopausal status, and metastatic disease at presentation (p = 0.002, 0.013, and 0.035, respectively). Ten-year actuarial OS for not classic and difficult to assign were not significantly different and were grouped for further analyses. Ten-year OS was 29.7% among patients with the classic sign triad versus 57.2% for non-classic (p < 0.0001). The multivariate Cox regression model adjusting for clinical staging (p < 0.0001) and TNBC status (<0.0001) demonstrated classic presentation score significantly associated with poorer OS time (HR 2.6, 95% CI 1.7-3.9, p < 0.0001). Conclusions A triad of classic IBC signs independently predicted OS in patients diagnosed with IBC. Further work is warranted to understand the biology related to clinical signs and further extend the understanding of physical examination findings in IBC.
引用
收藏
页码:6261 / 6272
页数:12
相关论文
共 50 条
  • [21] Effects of young age at presentation on survival in breast cancer
    Nagi S El Saghir
    Muhieddine Seoud
    Mazen K Khalil
    Maya Charafeddine
    Ziad K Salem
    Fady B Geara
    Ali I Shamseddine
    BMC Cancer, 6
  • [22] Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival
    Siamakpour-Reihani, Sharareh
    Owzar, Kouros
    Jiang, Chen
    Scarbrough, Peter M.
    Craciunescu, Oana I.
    Horton, Janet K.
    Dressman, Holly K.
    Blackwell, Kimberly L.
    Dewhirst, Mark W.
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2015, 31 (04) : 386 - 395
  • [23] THE IMPACT OF THE FIRST 3 YEARS OF BREAST-CANCER SCREENING ON THE OVERALL PRESENTATION OF BREAST-CANCER
    MOODY, C
    CORDER, A
    MULLEE, MA
    GUYER, P
    RUBIN, C
    CROSS, M
    ROYLE, GT
    TAYLOR, I
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1994, 87 (05) : 259 - 262
  • [24] Local Control, Aggressive Surgery, and Overall Survival for Breast Cancer
    Theodore Liakakos
    Efstathios G. Lykoudis
    Annals of Surgical Oncology, 2008, 15 : 1544 - 1546
  • [25] The overall survival of breast cancer patients without adjuvant therapy
    Onishi, Sakura
    Sawaki, Masataka
    Ishiguro, Junko
    Kataoka, Ayumi
    Iwase, Madoka
    Sugino, Kayoko
    Adachi, Yayoi
    Gondo, Naomi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Matsuo, Keitaro
    Yatabe, Yasushi
    Iwata, Hiroji
    SURGERY TODAY, 2019, 49 (07) : 610 - 620
  • [26] The overall survival of breast cancer patients without adjuvant therapy
    Sakura Onishi
    Masataka Sawaki
    Junko Ishiguro
    Ayumi Kataoka
    Madoka Iwase
    Kayoko Sugino
    Yayoi Adachi
    Naomi Gondo
    Haruru Kotani
    Akiyo Yoshimura
    Masaya Hattori
    Keitaro Matsuo
    Yasushi Yatabe
    Hiroji Iwata
    Surgery Today, 2019, 49 : 610 - 620
  • [27] The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients
    Korhonen, T.
    Kuukasjarvi, T.
    Huhtala, H.
    Alarmo, E. -L.
    Holli, K.
    Kallioniemi, A.
    Pylkkanen, L.
    BREAST, 2013, 22 (06) : 1119 - 1124
  • [28] The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer
    Ditsch, Nina
    Toth, Bettina
    Mayr, Doris
    Lenhard, Miriam
    Gallwas, Julia
    Weissenbacher, Tobias
    Dannecker, Christian
    Friese, Klaus
    Jeschke, Udo
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2012, 60 (02) : 121 - 129
  • [29] Treatment of Internal Mammary Nodes is Associated With Improved Overall Survival in Breast Cancer: A Meta-Analysis
    Shaikh, Parvez Memet
    Mulherkar, Ria
    Khasawneh, Mohammad T.
    Clump, David
    Hazard-Jenkins, Hannah
    Hafez, Maria
    Vargo, John A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (02): : 81 - 87
  • [30] Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer
    Rojo, F.
    Garcia-Parra, J.
    Zazo, S.
    Tusquets, I.
    Ferrer-Lozano, J.
    Menendez, S.
    Eroles, P.
    Chamizo, C.
    Servitja, S.
    Ramirez-Merino, N.
    Lobo, F.
    Bellosillo, B.
    Corominas, J. M.
    Yelamos, J.
    Serrano, S.
    Lluch, A.
    Rovira, A.
    Albanell, J.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1156 - 1163